openPR Logo
Press release

Nephrotic Syndrome Market Insights 2034 by Delveinsight | Vertex Pharmaceuticals, Chinook Therapeutics, Novartis, Boehringer Ingelheim, Hoffmann-La Roche, Biogen

09-11-2024 12:07 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Nephrotic Syndrome Market

Nephrotic Syndrome Market

The market size of Nephrotic Syndrome is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as Vertex Pharmaceuticals, Chinook Therapeutics, Novartis, Boehringer Ingelheim, Hoffmann-La Roche, Biogen

[Nevada, United States] - DelveInsight's "Nephrotic Syndrome Market Insights, Epidemiology, and Market Forecast 2034." report offers a detailed examination of Nephrotic Syndrome, covering historical and predicted epidemiology, market trends, and treatment scenarios in the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.

To Know in detail about the Nephrotic Syndrome Market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; https://www.delveinsight.com/report-store/nephrotic-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr

Key Findings from the Nephrotic Syndrome Market Report:
The Nephrotic Syndrome market size is poised for significant growth, with an anticipated Compound Annual Growth Rate (CAGR) during the study period (2020-2034).
In August, 2024: Hoffmann-La Roche announced a study to assess the efficacy, safety, and pharmacokinetics (PK)/pharmacodynamics (PD) of obinutuzumab compared with mycophenolate mofetil (MMF) in children and young adults (aged >= 2-25 years) with frequently relapsing nephrotic syndrome (FRNS) or steroid-dependent nephrotic syndrome (SDNS).
In July, 2024: Walden Biosciences announced that a placebo-controlled study is being conducted to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of WAL0921 in subjects with glomerular kidney disease and proteinuria, including diabetic nephropathy and rare glomerular kidney diseases (primary focal segmental glomerulosclerosis [FSGS], treatment-resistant minimal change disease [TR MCD], primary immunoglobulin A nephropathy [IgAN], and primary membranous nephropathy [PMN]).
In June, 2024: Travere Therapeutics, Inc. announced that their study will investigate whether RE-021 (Sparsentan), a selective dual-acting receptor antagonist with affinity for endothelin (A type) and angiotensin II receptors (Type 1), is safe and effective in treating patients with focal segmental glomerulosclerosis (FSGS).
The total diagnosed cases of Nephrotic Syndrome in the 7MM were ~788 thousand in 2023. These cases are expected to increase during the forecast period (2024-2034).
Among the 7MM, EU4 and the UK accounted for approximately 47% of diagnosed prevalent cases of Nephrotic Syndrome in 2023
Key Nephrotic Syndrome Companies are as follows: Vertex Pharmaceuticals, Chinook Therapeutics, Novartis, Boehringer Ingelheim, Hoffmann-La Roche, Biogen , Cerium Pharmaceuticals, Otsuka Pharmaceutical Development & Commercialization, Visterra, Ionis Pharmaceuticals, Kezar Life Sciences, Alpine Immune Sciences, Dimerix Bioscience, Advanz Pharma, Apellis Pharmaceuticals, Vera Therapeutics, Inc., AstraZeneca, HI-Bio.
Key Nephrotic Syndrome Therapies are as follows: Tacrolimus, ACTH, Mycophenolate mofetil, Prednisone, Mizoribine (MZR), Cyclophosphamide (CTX), Huaiqihuang granule, Prednisone, Levamisole placebo, Obinutuzumab, MMF, Prednisone, Rituximab, Belimumab, Tacrolimus, Abatacept, Obinutuzumab, WAL0921, Irbesartan and more…
Launching multiple stage Nephrotic Syndrome pipeline products is expected to revolutionize market dynamics, further propelling market growth.

Dive into our detailed Nephrotic Syndrome market research report to uncover actionable insights, industry forecasts, and competitive analysis @ https://www.delveinsight.com/sample-request/nephrotic-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr

Nephrotic Syndrome Overview:
Nephrotic syndrome is a clinical syndrome defined by massive proteinuria (greater than 40 mg/m2/h) responsible for hypoalbuminemia (less than 30 g/L), with resulting hyperlipidemia, edema, and various complications

Nephrotic Syndrome Drugs Uptake and Pipeline Development Activities:
The drugs uptake section highlights the rate at which newly launched or soon-to-be-launched drugs are adopted during the study period. The report examines market uptake by drugs, patient adoption of therapies, and sales data for each drug. It also offers insights into the Nephrotic Syndrome pipeline development, assessing therapeutic candidates at different stages and the key companies participating in these activities.

For more information about Nephrotic Syndrome companies working in the treatment market, visit https://www.delveinsight.com/sample-request/nephrotic-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr

Nephrotic Syndrome Therapies and Key Companies:
Atacicept: Vera Therapeutics
Atrasentan: Chinook Therapeutics/ Novartis
Obinutuzumab, MMF, Prednisone: Hoffmann-La Roche
Tacrolimus, Prednisolone: Astellas Pharma Korea, Inc.
Abatacept: Bristol-Myers Squibb
NC-503: Bellus Health Inc. - a GSK company
Placebo, 100 mg AP1189: SynAct Pharma Aps

Nephrotic Syndrome Epidemiology:
The epidemiology section provides insights into historical, current, and forecasted trends in the seven major countries (7MM) from 2020 to 2034. It explores various studies and opinions to recognize the causes of current and forecasted trends. The segmentation includes total prevalence, severity-based prevalence, gender-specific prevalence, and diagnosed cases of episodic and chronic Nephrotic Syndrome.

Seize Market Opportunities with Our Expert Analysis! Our report delivers valuable insights into market dynamics, key players, and emerging trends @ https://www.delveinsight.com/sample-request/nephrotic-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Nephrotic Syndrome Epidemiology Segmentation:
The Nephrotic Syndrome market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
Nephrotic Syndrome Total Prevalence
Prevalent Cases of Nephrotic Syndrome by severity
Gender-specific Prevalence of Nephrotic Syndrome
Diagnosed Cases of Episodic and Chronic Nephrotic Syndrome

Nephrotic Syndrome Market Drivers and Barriers:
The Nephrotic Syndrome Market Forecast report highlights key drivers and barriers shaping the Nephrotic Syndrome market dynamics, providing insights into factors influencing growth and challenges that may be encountered.

Stay Ahead in a Competitive Landscape with Our Exhaustive Market Research Report-Dive Into Detailed Analysis, Key Trends, and Future Projections @ https://www.delveinsight.com/sample-request/nephrotic-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr

Scope of the Nephrotic Syndrome Market Report:
Study Period: 2020-2034
Coverage: 7MM (The United States, EU5, and Japan)
Key Nephrotic Syndrome Companies: Vertex Pharmaceuticals, Chinook Therapeutics, Novartis, Boehringer Ingelheim, Hoffmann-La Roche, Biogen , Cerium Pharmaceuticals, Otsuka Pharmaceutical Development & Commercialization, Visterra, Ionis Pharmaceuticals, Kezar Life Sciences, Alpine Immune Sciences, Dimerix Bioscience, Advanz Pharma, Apellis Pharmaceuticals, Vera Therapeutics, Inc., AstraZeneca, HI-Bio.
Key Nephrotic Syndrome Therapies: Tacrolimus, ACTH, Mycophenolate mofetil, Prednisone, Mizoribine (MZR), Cyclophosphamide (CTX), Huaiqihuang granule, Prednisone, Levamisole placebo, Obinutuzumab, MMF, Prednisone, Rituximab, Belimumab, Tacrolimus, Abatacept, Obinutuzumab, WAL0921, Irbesartan
Nephrotic Syndrome Therapeutic Assessment: Current marketed and emerging therapies
Nephrotic Syndrome Market Dynamics: Nephrotic Syndrome Market drivers and Nephrotic Syndrome barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
Nephrotic Syndrome Unmet Needs: Insights into unmet needs, KOL's views, Analyst's views, Market Access, and Reimbursement.

To access the full report and gain a deeper understanding of Nephrotic Syndrome market outlook, drug uptake, treatment scenario, and epidemiology trends: https://www.delveinsight.com/sample-request/nephrotic-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr

Table of Content:

1. Key Insights
2. Report Introduction
3. Nephrotic Syndrome Market Overview at a Glance
4. Epidemiology and Market Methodology of Nephrotic Syndrome
5. Executive Summary of Nephrotic Syndrome
6. Key Events
7. Nephrotic Syndrome: Disease Background and Overview
8. Epidemiology and Patient Population
9. Patient Journey
10. Marketed Drugs
11. Emerging Therapies
12. Nephrotic Syndrome: Seven Major Market Analysis
13. KOL Views
14. SWOT Analysis
15. Unmet Needs
16. Market Access and Reimbursement
17. Appendix
18. DelveInsight Capabilities
19. Disclaimer

List of Top Selling Market Research Reports in 2024

Surgical Energy Generators Market- https://www.delveinsight.com/report-store/surgical-energy-generators-market
Surgical Sealant Tissue Patch Market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Surgical Stapling Devices Market- https://www.delveinsight.com/report-store/surgical-stapling-devices-market
Vital Sign Monitoring Devices Market- https://www.delveinsight.com/report-store/vital-sign-monitors-external-remote-patient-monitoring-devices-market
Syphilis Market- https://www.delveinsight.com/report-store/syphilis-market
Vitreoretinal Surgery Devices Market- https://www.delveinsight.com/report-store/vitreoretinal-surgery-devices-market
Pelvic Organ Prolapse Market- https://www.delveinsight.com/report-store/pelvic-organ-prolapse-market
Scoliosis Market- https://www.delveinsight.com/report-store/scoliosis-market
SGLT2 Inhibitors Market- https://www.delveinsight.com/report-store/sglt2-inhibitors-market
Urinary Catheters Market- https://www.delveinsight.com/report-store/urinary-catheters-market
Carcinoid Syndrome Market- https://www.delveinsight.com/report-store/carcinoid-syndrome-market
Cardiac Monitoring Devices Market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
Varicose Vein Treatment Devices Market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Bone Growth Stimulators Market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Skin Neoplasms Market- https://www.delveinsight.com/report-store/skin-neoplasms-market
Thrombectomy Devices Market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
Novel Drug Delivery Devices Market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Lymphedema Market- https://www.delveinsight.com/report-store/lymphedema-market
Artificial Disc Market- https://www.delveinsight.com/report-store/artificial-disc-market
Exocrine Pancreatic Insufficiency Market- https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
Fabry Disease Market- https://www.delveinsight.com/report-store/fabry-disease-market
Overactive Bladder Market- https://www.delveinsight.com/report-store/overactive-bladder-oab-market
Total Knee Arthroplasty Market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Hip Replacement Devices Market- https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
Lactose Intolerance Market- https://www.delveinsight.com/report-store/lactose-intolerance-market
HDAC Inhibitors Market- https://www.delveinsight.com/report-store/hdac-inhibitors-market
Ventral Hernia Market- https://www.delveinsight.com/report-store/ventral-hernia-market
Facial Lines Market- https://www.delveinsight.com/report-store/facial-lines-market
Medical Marijuana Market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Microscopy Device Market- https://www.delveinsight.com/report-store/microscopy-device-market

About DelveInsight

DelveInsight is a leading market research firm providing insightful solutions and services to pharmaceutical and life sciences companies. With a commitment to delivering accurate and comprehensive reports, DelveInsight empowers businesses to make informed decisions and navigate the complexities of the healthcare industry.

Company Name: DelveInsight Business Research LLP
Contact Person: Ram Kapoor
Email: info@delveinsight.com
Contact No.: +91-9650213330
City: 304 S. Jones Blvd #2432, Las Vegas

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nephrotic Syndrome Market Insights 2034 by Delveinsight | Vertex Pharmaceuticals, Chinook Therapeutics, Novartis, Boehringer Ingelheim, Hoffmann-La Roche, Biogen here

News-ID: 3652177 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Nephrotic

Nephrotic Syndrome Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Nephrotic Syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Nephrotic Syndrome, historical and forecasted epidemiology as well as the Nephrotic Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. The latest healthcare forecast report provides an in-depth analysis of Nephrotic Syndrome, offering comprehensive insights into the Nephrotic Syndrome revenue trends, prevalence, and treatment landscape. The
Nephrotic Syndrome Treatment Market Size, Share, Growth, Trends, and Forecast 20 …
July 2025 | By Shweta Raskar, Business Development Specialist at Prophecy Market Insights Prophecy Market Insights has recently published a comprehensive research report on the Nephrotic Syndrome Treatment Market, offering in-depth insights into key growth dynamics, future opportunities, and competitive landscape shaping the market from 2025 to 2035. The report spans 145+ pages, delivering valuable intelligence for pharmaceutical companies, healthcare providers, investors, and policymakers. 📎 Get a Free Sample Report Here: https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/5788 🔑 Key
Nephrotic Syndrome Market Outlook 2025-2034: Key Trends, Growth Drivers, and Mar …
How Are the key drivers contributing to the expansion of the nephrotic syndrome market? The increasing incidence of kidney diseases is anticipated to drive the growth of the nephrotic syndrome market. Kidney diseases, which impair the kidneys' ability to filter waste from the blood, are rising due to factors like diabetes, hypertension, obesity, and aging populations. Nephrotic syndrome, which causes damage to the kidneys' glomeruli and impairs filtration, contributes to the
Nephrotic Syndrome Treatment Market Size, Emerging Drugs, Market Outlook, and Co …
DelveInsight's "Nephrotic Syndrome Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Nephrotic Syndrome, historical and forecasted epidemiology, and the Nephrotic Syndrome market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. Unlock detailed insights into the Nephrotic Syndrome Market by downloading the comprehensive report from DelveInsight @ Nephrotic Syndrome Therapeutics Market- https://www.delveinsight.com/sample-request/nephrotic-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the
Nephrotic Syndrome Diagnostics & Therapeutics Market Demand Analysis, Growth, Tr …
The global nephrotic syndrome diagnostics & therapeutics market is anticipated to grow at a CAGR of around 5.6% during the forecast period (2024-2031). The key factor to drive the market growth includesthe increasing prevalence of diabetes that results in increased chances of nephrotic syndrome. For instance, In the European Union, approximately 32.3 million adults were diagnosed with diabetes in 2019, up from an estimated 16.8 million adults in 2000. In
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Market - Transforming Kid …
Newark, New Castle, USA: The "Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Market: https://www.growthplusreports.com/report/focal-segmental-glomerulosclerosis-fsgs-therapeutics-market/8837 This latest report